Cardium Therapeutics (CXM) Reports In-Line Q1 Loss of 2c/Share

Go back to Cardium Therapeutics (CXM) Reports In-Line Q1 Loss of 2c/Share
Cardium Therapeutics, Inc. (NYSE: CXM) Delayed: 7.18 +0.05 (0.70%)
Previous Close $7.13    52 Week High $1.44 
Open $7.09    52 Week Low $0.06 
Day High $7.19    P/E N/A 
Day Low $7.09    EPS $-1.24 
Volume 86,093